(Q47954880)

7 February 2018

title

Quality of life, fatigue, depression and cognitive impairment in Lyme neuroborreliosis. (English)

1 reference

7 February 2018

0 references

1 reference

cognitive dysfunction

1 reference

Rick Dersch

1

1 reference

7 February 2018

Antonia A Sarnes

2

1 reference

7 February 2018

Monika Maul

3

1 reference

7 February 2018

Tilman Hottenrott

4

1 reference

7 February 2018

Annette Baumgartner

5

1 reference

7 February 2018

Sebastian Rauer

6

1 reference

7 February 2018

Oliver Stich

7

1 reference

7 February 2018

publication date

26 September 2015

1 reference

7 February 2018

published in

Journal of Neurology

1 reference

7 February 2018

volume

262

1 reference

7 February 2018

issue

11

1 reference

7 February 2018

page(s)

2572-2577

1 reference

7 February 2018

https://scigraph.springernature.com/pub.10.1007/s00415-015-7891-4

exact match

0 references

cites work

Clinical courses of acute and chronic neuroborreliosis following treatment with ceftriaxone

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7891-4

EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7891-4

The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7891-4

Antiscience and ethical concerns associated with advocacy of Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7891-4

Subjective symptoms after treatment of early Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7891-4

Evaluation of study patients with Lyme disease, 10-20-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7891-4

Lyme neuroborreliosis in children: a prospective study of clinical features, prognosis, and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7891-4

European neuroborreliosis: quality of life 30 months after treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7891-4

Lyme encephalopathy: long-term neuropsychological deficits years after acute neuroborreliosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7891-4

EQ-5D: a measure of health status from the EuroQol Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7891-4

Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7891-4

Case-control studies: research in reverse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7891-4

European neuroborreliosis: neuropsychological findings 30 months post-treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7891-4

Evidence-based guidelines for the management of Lyme disease

21 January 2018

1 reference

12 December 2020

Bannwarth's syndrome and the enlarged neurological spectrum of arthropod-borne borreliosis

1 reference

12 December 2020

Incidence of Lyme borreliosis in the Würzburg region of Germany

1 reference

12 December 2020

Death due to community-associated Clostridium difficile in a woman receiving prolonged antibiotic therapy for suspected lyme disease

1 reference

12 December 2020

The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus

1 reference

12 December 2020

1 reference

12 December 2020

5-y Follow-up Study of Patients with Neuroborreliosis

1 reference

12 December 2020

Death from inappropriate therapy for Lyme disease

1 reference

12 December 2020

10.1007/S00415-015-7891-4

Identifiers

DOI

1 reference

7 February 2018

release_cghupzbctbegrouppnz25nxqrm

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cghupzbctbegrouppnz25nxqrm

24 November 2022

mapped directly with Wikidata item

PubMed ID

26410742

1 reference

7 February 2018